Rationale for use of antimicrobial combinations.

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Antimicrobial combinations are widely used to broaden spectrum coverage and prevent resistance.
• Antagonism can occur, particularly with bacteriostatic agents combined with bactericidal ones, or cefoxitin with other beta-lactams.
• Combination therapy is crucial for resistant organisms like methicillin-resistant staphylococci and mycobacteria.

Purpose of the Study:

• To explore synergistic antimicrobial combinations and their mechanisms.
• To identify strategies for enhancing antimicrobial activity through drug combinations.
• To investigate the potential of combining drugs targeting complementary bacterial targets.

Main Methods:

• Review of existing literature on antimicrobial combinations and interactions.
• Analysis of specific synergistic mechanisms, including sequential pathway inhibition and complementary protein binding.
• In vitro studies examining the synergistic effects of amdinocillin with other beta-lactams.

Main Results:

• Three primary types of synergistic antimicrobial interactions were identified: cell wall synthesis inhibitors with aminoglycosidic aminocyclitols, beta-lactamase inhibitors with beta-lactams, and agents acting on sequential metabolic pathways.
• Combinations of two beta-lactam antibiotics binding to complementary penicillin-binding proteins show synergistic potential.
• Amdinocillin, binding to penicillin-binding protein 2, demonstrated in vitro synergism when combined with other penicillins and cephalosporins.

Conclusions:

• Synergistic antimicrobial combinations offer a strategy to enhance efficacy and potentially reduce toxicity.
• Understanding specific drug interactions, such as complementary protein binding, is key to developing effective combination therapies.
• Further research into synergistic combinations is warranted to combat resistant bacterial infections.